CSF3 and neutropenia: Clinical trials have shown that polyethylene glycol-conjugated G-CSF prevents neutropenia and febrile neutropenia in patients receiving oxaliplatin-containing chemotherapy (Kitagawa et al., 2020; Macaire et al., 2020).